Skip to content

MDMA research published in 2008

Page 4 of 4: studies 61 to 80 of 80, newest first. Back to the MDMA overview

Studies

Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Behavioural Pharmacology March 2008 Matthew R. Skelton, Michael T. Williams, Charles V. Vorhees

+/-3,4-Methylenedioxymethamphetamine (MDMA) is a chemical derivative of amphetamine that has become a popular drug of abuse and has been shown to deplete serotonin in the brains of users and animals exposed to it. To date, most studies have investigated the effects of MDMA on adult animals. With a majority of users of MDMA being young adults, the chances of the users becoming pregnant and...

Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys.

Behavioural Pharmacology March 2008 Matthew L Banks, Paul W Czoty, Jon E. Sprague et al.

In monkeys, elevating ambient temperature has been shown to increase sensitivity to 3,4-methylenedioxymethamphetamine (MDMA) reinforcement. Earlier rodent studies have shown that elevations in thyroid levels (hyperthyroidism) parallel changes in elevating the ambient temperature on MDMA-induced thermogenesis, but the interaction has not been examined in monkeys. This study was designed to...

Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects.

Psychopharmacology March 2008 Sami Ben Hamida, Erin Plute, Brigitte Cosquer et al.

(+/-)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is often taken recreationally with ethanol (EtOH). In rats, EtOH may potentiate MDMA-induced hyperactivity, but attenuate hyperthermia. Experiment 1 compared the interactions between EtOH (1.5 g/kg) and MDMA (6.6 mg/kg) with EtOH + cocaine (COCA; 10 mg/kg) and EtOH + amphetamine (AMPH; 1 mg/kg) on locomotor activity and thermoregulation....

Discriminative stimulus effects of hallucinogens and psychostimulants in S(+)‐MDMA, and R(−)‐MDMA trained mice

The FASEB Journal March 1, 2008 Kevin Sean Murnane, Leonard L. Howell, William E Fantegrossi

3,4‐Methylenedioxymethamphetamine (MDMA) is an amphetamine derivative with increasingly widespread abuse. MDMA has been difficult to classify as a stimulant or hallucinogen because it shares effects with both drug classes. Furthermore, racemic MDMA is composed of two isomers that vary in terms of behavioral effects rather than simple potency differences. Specifically, the R(−) isomer of MDMA...

Memory and mood during the night and in the morning after repeated evening doses of MDMA

Journal of Psychopharmacology February 28, 2008 KPC Kuypers, M. Wingen, Jg Ramaekers 28 citations

Previously it has been shown that MDMA causes memory impairment during daytime testing. However, MDMA is usually taken in the evening or during the night. In addition, it is known that sleep deprivation also causes memory impairment. The present study aimed to assess whether evening doses of MDMA added to, or interacted with the memory impairment due to sleep deprivation. Fourteen healthy...

Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers

Psychopharmacology February 28, 2008 Glenn Dumont, E. Wezenberg, M. M. G. J. Valkenberg et al. 50 citations

Co-administration of MDMA and ethanol did not exacerbate the effects of either drug alone. Although the impairment of performance by all drug conditions was relatively moderate, all induced significant impairment of cognitive function.

Understanding recreational ecstasy use in the United States: a qualitative inquiry.

The International journal on drug policy February 20, 2008 Masuma Bahora, Claire E Sterk, Kirk W Elifson

Background: Ecstasy use has increasingly become popular among young adults, many of whom view it as a safe drug with no or limited negative social and health consequences. In this paper, we explore the perceptions of ecstasy users about its recreational use as well as regarding the normalisation of use. Methods: The study participants were recruited using targeted and theoretical sampling. To...

DOI: 10.1016/j.drugpo.2007.10.003 (opens in new tab) Full text (opens in new tab) Humans Amphetamine-related disorders N-methyl-3,4-methylenedioxyamphetamine Hallucinogens +11

Oxidative stress in rat kidneys due to 3,4-methylenedioxymetamphetamine (ecstasy) toxicity.

Nephrology February 2008 Milica Ninković, Vesna Selaković, Mirjana Dukić et al.

The mechanism of MDMA (3,4-methylenedioxymethamphetamine)-induced toxicity is believed to be, in part, due to enhanced oxidative stress. As MDMA is eliminated via the kidney, the aim of this study was to investigate whether MDMA created conditions of oxidative stress within rat kidney. Adult male Wistar rats were divided into three groups, control treatment (water), acute MDMA administration...

Death from a possible anaphylactic reaction to ecstasy.

Clinical Toxicology February 2008 Anny Sauvageau

Ecstasy (3,4 methylenedioxymethamphetamine, or MDMA) is a recreational drug widely used among young people in discos or rave parties (1,2). MDMA is taken because it gives a feeling of euphoria, enhances energy and sociability, and heightens sensations and sexual arousal. However, several side effects have been described: headache, nausea, anorexia, xerostomia, insomnia, myalgia, trismus, and...

In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.

Experimental and Clinical Psychopharmacology February 1, 2008 William E Fantegrossi 30 citations

The chiral nature of the MDMA molecule gives rise to two enantiomers, each of which is biologically active. This review attempts to cover the author's research into the in vivo effects of MDMA and its enantiomers, as well as other relevant publications which pertain to this topic. No particular differences between the capacities of racemic MDMA and its enantiomers to maintain behavior were...

Ecstasy (MDMA) and oral health.

British Dental Journal January 26, 2008 H S Brand, S N Dun, A V Nieuw Amerongen

3,4-methylenedioxymethamphetamine (MDMA), more commonly known as 'ecstasy' or XTC, is frequently used by young adults in the major cities. Therefore, it is likely that dentists might be confronted with individuals who use ecstasy. This review describes systemic and oral effects of ecstasy. Life-threatening complications include hyperthermia, hyponatraemia and liver failure. In addition,...

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study

Journal of Psychopharmacology January 21, 2008 Susana de Sola Llopis, Mónica Miguélez-Pan, Jordi Peña‐Casanova et al. 58 citations

There is important preclinical evidence of long lasting neurotoxic and selective effects of ecstasy MDMA on serotonin systems in non-human primates. In humans long-term recreational use of ecstasy has been mainly associated with learning and memory impairments. The aim of the present study was to investigate the neuropsychological profile associated with ecstasy use within recreational polydrug...

MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor

Journal of Psychopharmacology January 21, 2008 Christopher D. Verrico, Laurie J. Lynch, Michele A. Fahey et al. 31 citations

Human MDMA (R,S-3,4-methylenedioxymethamphetamine) users display selective cognitive deficits after acute MDMA exposure, frequently attributed to serotonin deficits. We postulated that MDMA will compromize executive function in primates and that an inhibitor of the serotonin transporter (SERT) and the norepinephrine transporter (NET) but not the dopamine (DAT) transporter, will prevent...

DOI: 10.1177/0269881107083639 (opens in new tab) MDMA Ecstasy Norepinephrine transporter Serotonin transporter +5

Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.

Neuropsychopharmacology January 2008 Matthew L Banks, Paul W Czoty, H Donald Gage et al.

Although serotonin (5-HT) can interact with dopamine (DA) systems to modulate the subjective and reinforcing effects of psychostimulants such as cocaine and 3,4-methyldioxymethamphetamine (MDMA, ecstasy), the long-term effects of exposure to psychostimulants on brain 5-HT systems are not well characterized. The present study assessed 5-HT transporter (SERT) availability using positron emission...

The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.

Basic & Clinical Pharmacology & Toxicology January 2008 Sunniva Nyberg Karlsen, Olav Spigset, Lars Slørdal

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a known neurotoxin in animals. This review discusses the history, pattern of use, pharmacology, acute and long-term effects of MDMA. Emphasis is given to the concern that MDMA may induce long-term cognitive and psychiatric effects. MDMA is an illegal substance, and investigations of the effects of exposure in human beings have limitations and...

Self-reported psychopathology among young, low-income, female ecstasy users.

Journal of Addictive Diseases 2008 Z Helen Wu, Jacques G Baillargeon, Abbey B Berenson et al.

This study examined the association of ecstasy (methylenedioxy-methylamphethamine) use with psychopathology among young, low-income females who sought care at university family planning clinics in Texas between December 2001 and May 2003. Participants reported drug use history and eight problem behavior syndromes by using the Young Adult Self-Report. The prevalence of ecstasy use was...

The acute effects of 3,4-methylenedioxymethamphetamine on oxidative stress in rat brain

Medicinski pregled 2008 Ivan Simic, Zivorad Malicevic

Introduction Oxidative stress and oxygen free radicals are thought to play an important role in acute effects of a number of neurotoxic processes. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy), a ring substituted amphetamine derivate, has attracted a great deal of media attention in recent years due to its widespread abuse as recreational drug by the young generation. The aim of the present...

Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys.

Psychopharmacology January 2008 Matthew L Banks, Jon E. Sprague, Paul W Czoty et al.

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is frequently used in hot environments, such as rave parties. Studies in laboratory animals have shown that ambient temperature can alter the behavioral and neurochemical effects of MDMA. To examine the influence of ambient temperature on the relative reinforcing strength of MDMA and reinstatement of behavior previously maintained by MDMA is the...

Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).

Journal of Pharmacological Sciences 2008 Takayuki Nakagawa, Shuji Kaneko 44 citations

Psychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, they finally converge to common neural pathways. Several lines of evidence suggest that their chronic...

Dance Clubbing on MDMA and during Abstinence from Ecstasy/MDMA: Prospective Neuroendocrine and Psychobiological Changes

Neuropsychobiology 2008 A. C. Parrott, Jing Zhan Lock, A.c. Conner et al. 77 citations

<i>Background/Aims:</i> The present study is the first to prospectively compare a group of recreational Ecstasy users when dance clubbing on 3,4-methylenedioxymethamphetamine (MDMA) and when clubbing during abstinence from Ecstasy/MDMA. <i>Methods:</i> Twelve normal healthy volunteers (mean age = 23.2 years) were assessed at a Saturday night dance club under self-administered MDMA. On the other...